Olodaterol for the treatment of chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Olodaterol for the treatment of chronic obstructive pulmonary disease

Published:2016-08-01 Issue:15 Volume:73 Page:1135-1143
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Ramadan Wijdan H.¹,Kabbara Wissam K.¹,Abilmona Rosa M.²

Affiliation:

1. Department of Pharmacy Practice, School of Pharmacy, Lebanese American University, Byblos, Lebanon

2. Pharmalife Pharmacy, Beirut, Lebanon

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/73/15/1135/28450060/ajhp1135.pdf

Reference29 articles.

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2015). www.goldcopd.org/ (accessed 2015 Mar 12).

2. National Center for Health Statistics, Centers for Disease Control and Prevention. Deaths: final data for 2010 (May2013). www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_04.pdf (accessed 2015 Mar 12).

3. Long-acting β-agonists in the management of chronic obstructive pulmonary disease: current and future agents;Tashkin;Respir Res,2010

4. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs;Toy;Respir Med,2011

5. Pharmacology and therapeutics of bronchodilators;Cazzola;Pharmacol Rev,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells;Respiratory Research;2021-02-23

Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease

;Journal of Experimental Pharmacology;2020-12

3. Long-Acting Bronchodilator Use in the Management of Stable COPD;Annals of Pharmacotherapy;2017-12-19